Steiner S M, Morton P A
Cancer Res. 1984 Oct;44(10):4476-9.
We have demonstrated previously that there is a marked decrease in the level of labeled fucose incorporated into an amino acid fucoside, i.e., fucosyl-N-acetylglucosaminylasparagine (FL4c) in SV40-transformed human embryonic lung cells (SV40-WI-38) as compared to WI-38 cells (Morton, P.A., Klinger, M. M., and Steiner, S. Cancer Res., 42: 3022-3027, 1982). In the current study, we have observed that the reduction in labeled fucose incorporated into FL4c in the SV40-WI-38 cells is paralleled by reduced chemical quantity of that component. [3H]-Fucose pulse/chase and long-term fucose labeling/chase studies, in some instances in the presence of tunicamycin, have revealed that FL4c is a relatively stable end produce of N-linked-type glycoprotein metabolism. The relative metabolic stability argues against breakdown of FL4c as the basis for the markedly reduced level in the SV40-WI-38 cells. However, the transformed cells manifested an almost 3-fold higher level of alpha-L-fucosidase activity when p-nitrophenyl-alpha-fucoside was used as substrate. These results raise the possibility that the parent glycoprotein of FL4c might be more rapidly catabolized in the SV40-WI-38 cells than in the WI-38 cells. Whatever the biochemical basis for the decrease in level of FL4c in transformed human cells, it would seem to underlie a difference between normal and transformed cells in membrane glycoprotein catabolism.
我们之前已经证明,与WI-38细胞相比,在SV40转化的人胚肺细胞(SV40-WI-38)中,掺入氨基酸岩藻糖苷即岩藻糖基-N-乙酰葡糖胺基天冬酰胺(FL4c)的标记岩藻糖水平显著降低(莫顿,P.A.,克林格,M.M.,和施泰纳,S.《癌症研究》,42: 3022 - 3027,1982)。在当前研究中,我们观察到SV40-WI-38细胞中掺入FL4c的标记岩藻糖减少的同时,该成分的化学量也减少。[3H]-岩藻糖脉冲/追踪和长期岩藻糖标记/追踪研究,在某些情况下是在衣霉素存在下进行的,结果表明FL4c是N-连接型糖蛋白代谢的相对稳定的终产物。相对的代谢稳定性排除了FL4c分解作为SV40-WI-38细胞中水平显著降低的基础。然而,当对硝基苯基-α-岩藻糖苷用作底物时,转化细胞表现出几乎高3倍的α-L-岩藻糖苷酶活性。这些结果增加了一种可能性,即FL4c的前体糖蛋白在SV40-WI-38细胞中可能比在WI-38细胞中更快地被分解代谢。无论在转化的人细胞中FL4c水平降低的生化基础是什么,它似乎是正常细胞和转化细胞在膜糖蛋白分解代谢方面差异的基础。